2.06
+0.25(+13.81%)
Currency In USD
| Previous Close | 1.81 |
| Open | 1.85 |
| Day High | 2.11 |
| Day Low | 1.81 |
| 52-Week High | 3.38 |
| 52-Week Low | 0.82 |
| Volume | 2.79M |
| Average Volume | 2.99M |
| Market Cap | 57.74M |
| PE | -2.61 |
| EPS | -0.79 |
| Moving Average 50 Days | 1.38 |
| Moving Average 200 Days | 1.08 |
| Change | 0.25 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $1.14 as of February 05, 2025 at a share price of $2.06. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $234.36 as of February 05, 2025 at a share price of $2.06.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
GlobeNewswire Inc.
Yesterday at 1:30 PM GMT
Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endova
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
GlobeNewswire Inc.
Jan 21, 2025 1:30 PM GMT
Operations Leader to Enhance Operational Efficiencies by Managing Production Scale-up and Cost Reduction Activities to Support CommercializationBRAINTREE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of t
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
GlobeNewswire Inc.
Jan 13, 2025 1:30 PM GMT
Mr. Wilson has a Track Record of Leading Product Launches and Achieving Revenue Growth in the Endovascular Devices MarketBRAINTREE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY®